Paul Eckburg

Insider Reports History

Location
1785 Woodhaven Place, Mountain View, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Paul Eckburg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Eckburg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Medical Officer Common Stock 51.4K $983K $19.11 Mar 15, 2024 Direct
AN2 Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 60K Mar 15, 2024 Direct
AN2 Therapeutics, Inc. Chief Medical Officer Common 51.4K Mar 15, 2024 Direct

Insider Reports Filed by Paul Eckburg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 1 $0 4/A Mar 29, 2024 Chief Medical Officer
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 18, 2024 Chief Medical Officer
ANTX AN2 Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Medical Officer
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Chief Medical Officer
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Chief Medical Officer